Yahoo Canada Web Search

Search results

1. www.vrtx.comVertex Pharmaceuticals | Home

   www.vrtx.com

   • Cached

   Vertex is a biotechnology company that develops and commercializes drugs for serious diseases. Learn about its latest news, acquisitions, financial results, corporate responsibility and pain program.

   • Careers

     Important Notices: Recruitment & Staffing Agencies: Vertex...

   • Our Company

     Vertex Pharmaceuticals strikes at the core of serious...

   • Our Approved Medicines

     Vertex’s Inclusion, Diversity and Equity Priorities Our...

   • Our Science

     Chief Human Resources Officer Stephanie Franklin discusses...

   • Patients

     Creating transformative medicines truly takes a village....

   • Responsibility

     Vertex was named one of America’s Most Responsible Companies...

   • News

     The Investor Relations website contains information about...

   • Investors

     Contacting Vertex's Transfer Agent. Communication regarding...

2. en.wikipedia.org › wiki › Vertex_PharmaceuticalsVertex Pharmaceuticals - Wikipedia

   en.wikipedia.org › wiki › Vertex_Pharmaceuticals

   • Cached

   Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.

3. Videos

   • 

     2:11

     youtube.com

     The History and Future of Vertex Pharmaceuticals | Vertex Pharmaceuticals

     May 14, 2021

     12.9K Views

   • 

     2:36

     youtube.com

     Innovation is Our Lifeblood | Vertex Pharmaceuticals

     May 16, 2024

     151 Views

   • 

     1:04

     youtube.com

     Why Join Vertex Pharmaceuticals | Vertex Pharmaceuticals

     Apr 29, 2021

     1K Views

   View all

4. finance.yahoo.com › quote › VRTXVertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance

   finance.yahoo.com › quote › VRTX

   • Cached

   Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

5. www.vrtx.caVertex Pharmaceuticals | The Science of Possibility

   www.vrtx.ca

   • Cached

   Vertex is a biotechnology company that pursues scientific innovation to transform serious diseases like cystic fibrosis. Learn about their research, responsibility and career opportunities in Canada.

6. Top Stories

   • 

     Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day

     This was the stock's second consecutive day of gains.

     MarketWatch

     2 hours ago

   • 

     Yahoo Finance

     Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon).

     3 days ago

   • 

     Yahoo Finance

     Did Vertex Pharmaceuticals Just Invent the Next Ozempic?

     4 days ago

   • 

     Banker & Tradesman

     Vertex HQ Renewal Deals Blow to Lab Projects

     7 hours ago

   • The Motley Fool on MSN.com

     Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?

     2 weeks ago

   View all

7. www.vrtx.com › our-companyVertex Pharmaceuticals | Our Company

   www.vrtx.com › our-company

   • Cached

   Vertex is a biopharmaceutical company that creates transformative medicines for people with serious diseases. Learn about their mission, values, culture, R&D and recognition.

8. www.fool.com › investing › 2024/07/06Prediction: This Will Be Vertex Pharmaceuticals' New Billion ...

   www.fool.com › investing › 2024/07/06

   • Cached

   2 days ago · Vertex Pharmaceuticals (VRTX 0.91%) transformed the world of cystic fibrosis (CF) treatment when it launched its first product for the disease 12 years ago. Since then, it's built a CF treatment ...

9. news.vrtx.com › news-releases › news-release-detailsVertex and CRISPR Therapeutics Announce US FDA Approval of ...

   news.vrtx.com › news-releases › news-release-details

   • Cached

   Dec 8, 2023 · CASGEVY is a CRISPR/Cas9 genome-edited cell therapy for sickle cell disease (SCD) that offers the potential of a functional cure by reducing vaso-occlusive crises. Vertex leads global development and commercialization of CASGEVY, with support from CRISPR Therapeutics.

10. People also ask

    What does vertex do?

    • Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases.

    Vertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance

    finance.yahoo.com/quote/VRTX/

    See all results for this question

    Where is vertex based?

    • Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America.

    Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY

    news.vrtx.com/news-releases/news-release-details/vertex-and-crispr-therapeutics-announce-us-fda-approval

    See all results for this question

    Who is Vertex Pharmaceuticals?

    • Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.

    Vertex Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Vertex_Pharmaceuticals

    See all results for this question

    What diseases does vertex treat?

    • Vertex's product pipeline includes drug regimens targeting specialty diseases like sickle cell disease, beta thalassemia, Duchenne muscular dystrophy, alpha-1 antitrypsin deficiency, pain, and APOL1-mediated kidney diseases. In 2014, Vertex discontinued telaprevir.

    Vertex Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Vertex_Pharmaceuticals

    See all results for this question